{"id":"e-coli-etvax","safety":{"commonSideEffects":[{"rate":"null","effect":"Injection site pain"}]},"_chembl":{"chemblId":"CHEMBL1909064","moleculeType":"Unknown"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"ETVAX works by introducing a weakened form of E. coli to the body, which triggers an immune response and helps the body produce antibodies to fight off future E. coli infections.","oneSentence":"ETVAX is a vaccine that stimulates the immune system to produce antibodies against E. coli.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T03:59:12.745Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Prevention of E. coli infections"}]},"trialDetails":[{"nctId":"NCT05178134","phase":"PHASE2","title":"A Phase 2 Bridging Study to Assess the New Formulation of ETVAX","status":"COMPLETED","sponsor":"Scandinavian Biopharma AB","startDate":"2021-11-08","conditions":"Healty Volunteers, Preventable Disease, Vaccine","enrollment":280},{"nctId":"NCT03729219","phase":"PHASE2","title":"Prevention of Diarrheal Disease Due to Infection With Enterotoxigenic E. Coli (ETEC)","status":"COMPLETED","sponsor":"Scandinavian Biopharma AB","startDate":"2017-06-12","conditions":"Diarrhea","enrollment":749},{"nctId":"NCT02531802","phase":"PHASE1, PHASE2","title":"Enterotoxigenic Escherichia Coli (ETEC) ETVAX Vaccine Trial in Bangladesh","status":"COMPLETED","sponsor":"PATH","startDate":"2015-10","conditions":"Escherichia Coli Diarrhea","enrollment":475}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":20,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"E. coli ETVAX","genericName":"E. coli ETVAX","companyName":"Scandinavian Biopharma AB","companyId":"scandinavian-biopharma-ab","modality":"Biologic","firstApprovalDate":"","aiSummary":"The ETVAX vaccine is being studied for its safety, tolerability, and immunogenicity in preventing Escherichia coli diarrhea, specifically Enterotoxigenic Escherichia coli (ETEC) infections. The vaccine is being tested in a randomized, double-blind, placebo-controlled trial in Bangladesh.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}